NASDAQ •
Healthcare •
Biotechnology •
Quote as of 07/31/2026
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization1,181.57 mln
Float149 mln
Earnings Date08/11/2026
Piotroski F-Score
3
/ 9
Below average
Beneish M-Score
-4.87
Highly reliable
1-Year Forecast
13.78
Transformational upside
Relative Strength
20
/ 100
Significantly lagging
Debt / Equity
0.03
Debt-free
ROE
-62.74
Deeply negative
Business Description
Founded in 2011 and based in Vancouver, Washington, Absci Corporation is a clinical-stage company focused on discovering and developing antibody-based medicines. The company is currently advancing several drug candidates targeting conditions such as inflammatory bowel disease, hair loss, and cancer. To support its research, Absci works alongside a range of partners including Memorial Sloan Kettering Cancer Center, Twist Bioscience, Oracle Corporation, and Advanced Micro Devices.
